Pfizer

The United States hopes to begin coronavirus vaccinations in early December, a top government health official said on Nov. 22, the latest positive news to emerge even as cases surge across the worst-hit nation and elsewhere around the globe.

Doctor Valeriu Gheorghita, coordinator of the national COVID-19 vaccination campaign, said on Sunday evening that mobile vaccination centres will be set up to provide immunisation to people having difficulties moving and those with disabilities.

Thousands of citizens have already applied to take part in the tests for a candidate COVID-19 vaccine being developed by China, the country's health minister has said.

The officials on Nov. 20 announced that applications from ordinary citizens would be collected from citizens for the Chinese jab, whose phase three trials on volunteer health workers began in mid-September in Turkey.

Working in a news organization gives you the opportunity to meet important people with fascinating personal and professional histories. It is a sort of antidote to the toxicity of the public sphere.

The development of a vaccine against coronavirus is possible by October, according to Albert Bourlas, head of the pharmaceutical giant Pfizer.

In an interview with Kathimerini, he said the company he manages has a budget of 2 billion euros for the research that will lead to the discovery of the vaccine and the creation of antiviral drugs.

The death toll from the coronavirus spiked again in the United States, and Latin America's pandemic crisis deepened, as Europe's re-opening from lockdown grew bolder by the day.    

German Chancellor Angela Merkel on April 23 pledged significant funding for research on the novel coronavirus, underlining that a possible vaccine against COVID-19 should be made available to all countries.

There are many generous donation to fight COVID-19 in Bulgaria. Many Bulgarian and US companies have showed solidarity to Bulgarian Hospitals and initiatives. See some of them below:

An increasing number of major foreign firms are making small yet targeted investments in Greece. These are brands with an international presence and reputation, and, most importantly, significant scope for growth.

This flurry of activity started around seven months ago and is gaining greater momentum now that the first contracts have been inked.

The creation of Pfizer's digital hub in Thessaloniki is proceeding fast, with the digital innovation center soon set to join the multinational pharmaceutical company's network of such hubs around the world.